The news: Direct-to-consumer (D2C) telehealth company Hims & Hers Health published its “Let’s Talk About Sex: The 2022 Report,” billed as its first annual sex report.
The data: The report uncovered nine myths and one truth about Americans’ attitudes and behaviors around sex and sexuality.
While a provocative topic, the report isn’t exactly groundbreaking. The myths are familiar, ranging from “everyone’s having more sex than I am” to “men want sex, women want romance.”
The single truth: Americans are suddenly less confident in their sexual freedoms. That’s not surprising, given the timing of when this survey was fielded.
Zooming out: Hims & Hers had a breakout Q2 2022 thanks to more aggressive marketing and the launch of two apps, one for Hims and one for Hers in iOS, with Android versions coming soon.
The company more than doubled its marketing spend YoY to $60.5 million for the quarter vs. $27.9 million in Q2 2021.
That high spending paid off—subscriptions surged 80% YoY, hitting 817,000 at the end of Q2 2022.
Why it matters: Sex is at the center of the Hims & Hers brand.
Via telehealth, its clinicians can prescribe or recommend products to treat erectile dysfunction, other sexual performance issues, and hair loss—as well as the resulting anxiety and depression someone might feel if they’ve experienced any of those conditions.
The big takeaway: At the end of the day, we think the value of Hims & Hers’ new sex report lies more in the titillating topic than the novelty of its findings.
11 Times SquareNew York, NY 100361-800-405-0844